{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-098726","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2023-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.110086+00:00","generated_at":"2026-06-07T06:56:18.192252+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bluejay initiates SYMON multicenter study of Symphony IL-6 test in sepsis patients","bullets":["Study will monitor IL-6 in sepsis/septic shock patients admitted to ICU; aims to predict 28-day mortality.","Study design incorporates feedback from pre-submission meetings with the FDA held earlier in 2023.","Symphony System delivers results from whole blood in ~20 minutes; study listed on clinicaltrials.gov (NCT06181604).","CEO Neil Dey says study moves company 'one step closer to commercialization' and may identify competitive advantages."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-098726","json":"https://secwatch.observer/filing/0001213900-23-098726.json","markdown":"https://secwatch.observer/filing/0001213900-23-098726.md","text":"https://secwatch.observer/filing/0001213900-23-098726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390023098726/0001213900-23-098726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390023098726/ea190739-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:56:18.192252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}